Mariner
GBT

Mariner’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Mariner’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-27,904
Closed -$1.9M – 2889
2022
Q3 		$1.9M Buy
+27,904
New +$1.54M 0.01% 791

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mariner's GBT Position: Q4 2022 in Review

Mariner sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 27,904 shares — an estimated $1.9M sold.

Mariner first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $1.9M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Mariner reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Mariner sold 27,904 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $1.9M.
  • Mariner first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
  • Mariner's Global Blood Therapeutics, Inc. position peaked at $1.9M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Mariner's 13F filing for Q4 2022, filed 14 Feb 2023.